Harbin Pharmaceutical Group

Harbin Pharmaceutical Group Co., Ltd.
Company type	Public
Traded as	SSE: 600664
Industry	Pharmaceuticals
Predecessor	Harbin Pharmaceutical Administration
Founded	1988
Headquarters	Harbin, Heilongjiang, China
Area served	Worldwide
Owner	Harbin SASAC (38.25%); CITIC Capital (19.1%);
Number of employees	20,100 (2014)
Subsidiaries	GNC Holdings, LLC; Renmintongtai (SSE: 600829);
Chinese name
Simplified Chinese	哈药集团有限公司
Traditional Chinese	哈藥集團有限公司
Hanyu Pinyin
Transcriptions
Standard Mandarin
Hanyu Pinyin	Hāyào Jítuán Yǒuxiàn gōngsī
Shortened name
Simplified Chinese	哈药集团
Traditional Chinese	哈藥集團
Hanyu Pinyin
Transcriptions
Standard Mandarin
Hanyu Pinyin	Hāyào Jítuán
Website	hayao.com
	Footnotes / references;

Harbin Pharmaceutical Group Co., Ltd. (shortened to HPGC or Hayao) is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine (TCM) and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.

The company owns both Renmintongtai (人民同泰), a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.